China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) attributable profit rose to 3.24 billion yuan in the nine months through Sept. 30 from 2.70 billion yuan in the year-ago period.
Revenue at the drug company grew to 19.7 billion yuan from 18.6 billion yuan a year earlier, according to a Friday filing by parent China Resources Pharmaceutical (HKG:3320) with the Hong Kong Exchange.
Shares slid 2% during Monday's trading.
Price (HKD): $46.52, Change: $-0.92, Percent Change: -1.94%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。